PGP and cancer: This counterintuitive observation is known in literature and was attributed to cell-type specific activation of ATP-Binding Cassette (ABC) transporters in cancer cells, e.g., such as overexpression of P-glycoprotein 1 (ABCB1/P-gp), leading to paclitaxel resistance at higher concentrations [124–127].